ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

CUSIP: 82835W108

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 7 signals
Share change
+8,353,543
Put/Call ratio
34%
SEC-reported price per share
$17.45
Number of holders
185
Value change
+$149,943,852
Number of buys
107
Open additional details 1 more signal available
Number of sells
69
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
99,255,583

Security key

82835W108

Report period

Q2 2025

Institutions

185

Top holders

10

Ownership snapshot

Top reported holders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F 3/4/5 Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 11%
DEERFIELD MANAGEMENT COMPANY, L.P. 11%
ORBIMED ADVISORS LLC 8.4%
BlackRock, Inc. 4.3%
SR ONE CAPITAL MANAGEMENT, LP 4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F 3/4/5
Company · Director, 10%+ Owner
11%
$136,631,091
10,860,977 shares
31 Mar 2025
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
11%
$132,274,385
10,514,657 shares
31 Mar 2025
ORBIMED ADVISORS LLC
13F
Company
13F
8.4%
$104,269,456
8,288,510 shares
31 Mar 2025
BlackRock, Inc.
13F
Company
13F
4.3%
$54,081,269
4,298,988 shares
31 Mar 2025
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
13F
4%
$50,482,320
4,012,903 shares
31 Mar 2025
ALLIANCEBERNSTEIN L.P.
13F
Company
13F
4%
$49,348,887
3,922,805 shares
31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
185
Shares
84,521,210
Rows available
185
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
182
Q2 2025 holders
185
Holder diff
3
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .